5 notable developments in cardiac interventional procedures for women

Cardiology Today’s Intervention has compiled a list of recent research that has advanced the knowledge base for cardiac interventional procedures in women.

New-generation DES consistent, durable over 3 years in women with acute MI

New-generation drug-eluting stents were associated with significantly lower risk for death, MI, target lesion revascularization and stent thrombosis over 3 years vs. early-generation stents in women who presented with acute MI, according to a new analysis from the Women in Innovation and Drug-Eluting Stents Collaboration.

Pregnancy-associated spontaneous coronary artery dissection linked to maternal, fetal complications

Pregnancy-associated spontaneous coronary artery dissection is associated with involvement from the left anterior descending artery, the left main artery and multiple vessels, which can often lead to reduced ejection fraction, according to published findings.

PLATINUM Diversity: Race, sex, socioeconomic factors impact PCI outcomes

Women and minorities who undergo PCI with a drug-eluting stent appear to have greater risk for mortality and recurrent cardiac events within the first year of the procedure compared with white men, researchers reported at the Society for Cardiovascular Angiography and Interventions Annual Meeting.

ZES effective for treatment of CAD in small vessels at 1 year

A zotarolimus-eluting stent designed to treat CAD in very small coronary vessels was effective at preventing target lesion failure at 1 year, according to findings presented at EuroPCR and published in JACC: Cardiovascular Interventions. The findings could prove beneficial to women who require PCI, as women on average have smaller coronary vessels than men.

One-year TAVR outcomes superior in women vs. men

Compared with men, women undergoing transcatheter aortic valve replacement for significant aortic valve disease have superior 1-year survival, although they have a greater adjusted risk for in-hospital vascular complications, according to data from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (TVT) registry.